brigatinib
Total Payments
$1.5M
Transactions
289
Doctors
55
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $1.5M | 289 | 55 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 90 | 87.7% |
| Consulting Fee | $141,785 | 42 | 9.7% |
| Travel and Lodging | $31,100 | 65 | 2.1% |
| Food and Beverage | $5,462 | 91 | 0.4% |
| Space rental or facility fees (teaching hospital only) | $2,500 | 1 | 0.2% |
Payments by Type
Research
$1.3M
90 transactions
General
$180,846
199 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ALTA | ARIAD Pharmaceuticals, Inc. | $536,228 | 0 |
| ALTA 1L | ARIAD Pharmaceuticals, Inc. | $392,640 | 0 |
| AP26113 Phase I II | ARIAD Pharmaceuticals, Inc. | $222,627 | 0 |
| AP32788 Phase I II | ARIAD Pharmaceuticals, Inc. | $67,797 | 0 |
| Brigatinib EAP | ARIAD Pharmaceuticals, Inc. | $67,701 | 0 |
Top Doctors Receiving Payments for brigatinib
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Kansas City, KS | $1.3M | 91 |
| , MD | Medical Oncology | Aurora, CO | $15,095 | 4 |
| , MD | Hematology & Oncology | Orange, CA | $14,412 | 16 |
| , MD | Medical Oncology | Aurora, CO | $14,300 | 1 |
| , MD | Internal Medicine | Philadelphia, PA | $11,765 | 7 |
| , M.D | Hematology & Oncology | La Jolla, CA | $7,639 | 14 |
| , MD | Medical Oncology | Columbus, OH | $7,547 | 9 |
| , MD | Medical Oncology | Chicago, IL | $5,972 | 5 |
| , MD, MS | Internal Medicine | Tampa, FL | $5,912 | 13 |
| , MD | Medical Oncology | Seattle, WA | $5,554 | 8 |
| , MD | Internal Medicine | Orlando, FL | $5,346 | 8 |
| , MD | Hematology & Oncology | Deerfield Beach, FL | $5,014 | 7 |
| , MD PHD | Hematology & Oncology | Irvine, CA | $4,922 | 8 |
| , MD | Medical Oncology | Grand Rapids, MI | $4,847 | 8 |
| , MD, PHD | Hematology & Oncology | Columbus, OH | $4,814 | 6 |
| , MD, PHD | Hematology & Oncology | Nashville, TN | $4,655 | 8 |
| , MD | Hematology | Charlotte, NC | $4,485 | 5 |
| , MD | Internal Medicine | Detroit, MI | $4,444 | 6 |
| , M.D., PH.D | Student in an Organized Health Care Education/Training Program | Pembroke Pines, FL | $4,334 | 7 |
| , MD | Hematology | Dallas, TX | $4,177 | 6 |
| , M.D | Internal Medicine | Charlottesville, VA | $3,924 | 7 |
| , MD | Hematology & Oncology | Washington, DC | $3,909 | 4 |
| , MD,PHD | Medical Oncology | Duarte, CA | $3,600 | 1 |
| , M.D | Hematology | Santa Rosa, CA | $3,210 | 4 |
| , M.D | Hematology & Oncology | Los Angeles, CA | $2,813 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.5M
- Total Doctors 55
- Transactions 289
About brigatinib
brigatinib is a drug associated with $1.5M in payments to 55 healthcare providers, recorded across 289 transactions in the CMS Open Payments database. The primary manufacturer is ARIAD Pharmaceuticals, Inc..
Payment data is available from 2017 to 2017. In 2017, $1.5M was paid across 289 transactions to 55 doctors.
The most common payment nature for brigatinib is "Unspecified" ($1.3M, 87.7% of total).
brigatinib is associated with 5 research studies, including "ALTA" ($536,228).